Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:
U.S. signs agreement with AstraZeneca to develop, supply COVID-19 antibody treatment [?!]
One trial will evaluate the safety and efficacy of the experimental treatment to prevent infection for up to 12 months, in about 5,000 participants, while the second trial will evaluate post-exposure preventative and pre-emptive treatment in roughly 1,100 participants.
walks and talks like a vaccine, but
Trump credited Regeneron Pharmaceuticals Inc's REGN.O therapeutic for his recovery. Trump received Regeneron's treatment last week after he was diagnosed with COVID-19.
Johnson & Johnson fetus stem cell oppo campaign developing ...
by Cat on Fri Oct 9th, 2020 at 10:14:10 PM EST
[ Parent ]

Others have rated this comment as follows:

Display:

Occasional Series